Colchicine 0.5 mg orally once daily for 12 months.
Approved
Colchicine 0.5 mg orally once daily for 12 months. is one of 2 therapeutic programs targeting Colchicine. It is currently in Approved.
1
Indications
1
Total Trials
1
Active Trials
1
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
2 competitors in Colchicine
#DrugCompanyPhaseTrials
1Colcrys
Alnylam PharmaceuticalsApproved
Colchicine 0.5 mg orally once daily for 12 months.
SShenyang Northern Hospital
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Approved[1]
- Company
- SShenyang Northern Hospital